156 related articles for article (PubMed ID: 25034074)
1. Intravenous hydration (with or without rosuvastatin) should remain the cornerstone of the prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease.
Cecere N; Jadoul M; Labriola L
J Am Coll Cardiol; 2014 Jul; 64(3):332. PubMed ID: 25034074
[No Abstract] [Full Text] [Related]
2. Reply: Intravenous hydration (with or without rosuvastatin) should remain the cornerstone of the prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease.
Han Y
J Am Coll Cardiol; 2014 Jul; 64(3):332-3. PubMed ID: 25034073
[No Abstract] [Full Text] [Related]
3. Prevention: Rosuvastatin can prevent contrast-induced AKI.
Roberts A
Nat Rev Cardiol; 2013 Dec; 10(12):679. PubMed ID: 24165911
[No Abstract] [Full Text] [Related]
4. Do statins reduce the risk of contrast-induced acute kidney injury in patients undergoing coronary angiography or percutaneous coronary interventions?
Alpert MA
J Am Coll Cardiol; 2014 Jan 7-14; 63(1):80-2. PubMed ID: 24076280
[No Abstract] [Full Text] [Related]
5. Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease.
Han Y; Zhu G; Han L; Hou F; Huang W; Liu H; Gan J; Jiang T; Li X; Wang W; Ding S; Jia S; Shen W; Wang D; Sun L; Qiu J; Wang X; Li Y; Deng J; Li J; Xu K; Xu B; Mehran R; Huo Y
J Am Coll Cardiol; 2014 Jan 7-14; 63(1):62-70. PubMed ID: 24076297
[TBL] [Abstract][Full Text] [Related]
6. Impact of Rosuvastatin on contrast-induced acute kidney injury in patients at high risk for nephropathy undergoing elective angiography.
Abaci O; Arat Ozkan A; Kocas C; Cetinkal G; Sukru Karaca O; Baydar O; Kaya A; Gurmen T
Am J Cardiol; 2015 Apr; 115(7):867-71. PubMed ID: 25670636
[TBL] [Abstract][Full Text] [Related]
7. Short-term rosuvastatin treatment for the prevention of contrast-induced acute kidney injury in patients receiving moderate or high volumes of contrast media: a sub-analysis of the TRACK-D study.
Zhang J; Li Y; Tao GZ; Chen YD; Hu TH; Cao XB; Jing QM; Wang XZ; Ma YY; Wang G; Liu HW; Wang B; Xu K; Li J; Deng J; Han YL
Chin Med J (Engl); 2015 Mar; 128(6):784-9. PubMed ID: 25758273
[TBL] [Abstract][Full Text] [Related]
8. Statins for the prevention of contrast-induced acute kidney injury.
Ball T; McCullough PA
Nephron Clin Pract; 2014; 127(1-4):165-71. PubMed ID: 25343843
[TBL] [Abstract][Full Text] [Related]
9. [The PRATO-ACS study].
Marenzi G; Briguori C
G Ital Cardiol (Rome); 2013 Dec; 14(12):803-8. PubMed ID: 24336595
[No Abstract] [Full Text] [Related]
10. Rosuvastatin Treatment for Preventing Contrast-Induced Acute Kidney Injury After Cardiac Catheterization: A Meta-Analysis of Randomized Controlled Trials.
Yang Y; Wu YX; Hu YZ
Medicine (Baltimore); 2015 Jul; 94(30):e1226. PubMed ID: 26222855
[TBL] [Abstract][Full Text] [Related]
11. ACP Journal Club. Early high-dose rosuvastatin prevented contrast-induced acute kidney injury in non-ST-elevation ACS.
Molnar AO; Garg AX
Ann Intern Med; 2014 May; 160(10):JC9. PubMed ID: 24842443
[No Abstract] [Full Text] [Related]
12. Relationship between inflammation and benefits of early high-dose rosuvastatin on contrast-induced nephropathy in patients with acute coronary syndrome: the pathophysiological link in the PRATO-ACS study (Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Nephropathy and Myocardial Damage in Patients With Acute Coronary Syndrome Undergoing Coronary Intervention).
Toso A; Leoncini M; Maioli M; Tropeano F; Di Vincenzo E; Villani S; Bellandi F
JACC Cardiovasc Interv; 2014 Dec; 7(12):1421-9. PubMed ID: 25523533
[TBL] [Abstract][Full Text] [Related]
13. Effect of rosuvastatin and sevelamer on the progression of coronary artery calcification in chronic kidney disease: a pilot study.
Lemos MM; Watanabe R; Carvalho AB; Jancikic AD; Sanches FM; Christofalo DM; Draibe SA; Canziani ME
Clin Nephrol; 2013 Jul; 80(1):1-8. PubMed ID: 23442255
[TBL] [Abstract][Full Text] [Related]
14. Effects of statins on vascular endothelial function in hypercholesterolemic patients with type 2 diabetes mellitus: fluvastatin vs. rosuvastatin.
Tomizawa A; Hattori Y; Suzuki K; Okayasu T; Kase H; Satoh H; Kasai K
Int J Cardiol; 2010 Sep; 144(1):108-9. PubMed ID: 19174316
[No Abstract] [Full Text] [Related]
15. Early high-dose rosuvastatin and cardioprotection in the protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome (PRATO-ACS) study.
Leoncini M; Toso A; Maioli M; Tropeano F; Badia T; Villani S; Bellandi F
Am Heart J; 2014 Nov; 168(5):792-7. PubMed ID: 25440809
[TBL] [Abstract][Full Text] [Related]
16. Balancing the cardiometabolic benefits and risks of statins.
Watts GF; Ooi EM
Lancet; 2012 Aug; 380(9841):541-3. PubMed ID: 22883491
[No Abstract] [Full Text] [Related]
17. A randomized, double-blind study of fenofibric acid plus rosuvastatin compared with rosuvastatin alone in stage 3 chronic kidney disease.
Weinstein DL; Williams LA; Carlson DM; Kelly MT; Burns KM; Setze CM; Lele A; Stolzenbach JC
Clin Ther; 2013 Aug; 35(8):1186-98. PubMed ID: 23891363
[TBL] [Abstract][Full Text] [Related]
18. Rosuvastatin in patients undergoing hemodialysis.
Kassimatis TI; Konstantinopoulos PA
N Engl J Med; 2009 Jul; 361(1):93; author reply 94-5. PubMed ID: 19579277
[No Abstract] [Full Text] [Related]
19. Efficacy of oral hydration in the prevention of contrast-induced acute kidney injury in patients undergoing coronary angiography or intervention.
Akyuz S; Karaca M; Kemaloglu Oz T; Altay S; Gungor B; Yaylak B; Yazici S; Ozden K; Karakus G; Cam N
Nephron Clin Pract; 2014; 128(1-2):95-100. PubMed ID: 25378376
[TBL] [Abstract][Full Text] [Related]
20. Statins and contrast-induced acute kidney injury with coronary angiography.
Gandhi S; Mosleh W; Abdel-Qadir H; Farkouh ME
Am J Med; 2014 Oct; 127(10):987-1000. PubMed ID: 24852935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
